ArticleRSC advances2023
Synthesis, thermophysical characterization and thermal performance analysis of novel Cu-MXene hybrid nanofluids for efficient coolant applications.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Thermal Conductivity Enhancement of Cu- and Ag-Decorated MWCNT Hybrid Nanofluids Synthesized via Probe Ultrasonication.ChemistryOpen · 2026Article
- Novel Cu-MXene hybrid nanofluids for the experimental investigation of thermal performance in double pipe heat exchanger.Scientific reports · 2025Article
- Novel 2D Layered MXene Nanofluids for Enhancing the Convective Heat Transfer Performance of Double-Pipe Heat Exchangers.ACS omega · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hybrid nanofluids are considered as an alternative for conventional heat transfer fluids and mono nanofluids due to its remarkable enhancement in thermo-physical properties. However, there are some limitations in achieving the better thermo-physical properties due to the stability of nanoparticles in different base fluids at higher concentration. This work aims at synthesizing, thermo-physical characterization and thermal performance estimation of stable Cu-MXene based hybrid nanofluids using various base fluids at very low volume concentration of Cu and MXene nanostructures. Two step method is employed to prepare Cu-MXene hybrid nanofluids by dispersing the low volume concentration of as prepared Cu and MXene nanostructures (ranging from 0.01-0.05 vol%) containing SDS surfactant in various base fluids such as water, methanol, castor oil and silicon oil. Synthesized mono and hybrid nanofluids shows excellent stability against aggregation up to 7 days as evidenced from higher zeta potential values. Wettability studies conducted using contact angle measurement suggests that the castor oil, methanol and silicon oil based hybrid nanofluids exhibits hydrophilic behavior (showing contact angle less than 90°). Hybrid nanofluids display excellent enhancement in thermal conductivity at very low concentration of nanostructures (more than 70% for methanol based Cu-MXene hybrid nanofluid). Viscosity of the silicone oil based hybrid nanofluids show a remarkable enhancement followed by water, methanol and castor oil based hybrid nanofluids. Thermal conductivity and viscosity of hybrid nanofluids are effectively validated with existing theoretical models. Moreover, specific heat and pumping power of the hybrid nanofluids with respect to volume concentration of nanostructures are determined using the existing theoretical equations. Thermal performance of hybrid nanofluids was successfully estimated using Figure of Merit (FOM) analysis and suggested the better heat transfer fluid for improving the heat transfer performance under laminar and turbulent flow conditions for efficient cooling applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.